Funding

Axol Bioscience

United Kingdom · Biotech

Provider of human induced pluripotent stem cell (iPSC) technologies

Visit axolbio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$2.8MBroadOak Capital Partners — Role not disclosedRoslin Foundation — Role not disclosed

Investors

BroadOak Capital PartnersUndisclosedRoslin FoundationUndisclosed

Coverage

Jan 13, 2026Axol Bioscience · Undisclosed

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesaxolbio.com ↗